Related Experiment Video
Updated: Aug 16, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange
Bekir Tanriover1, Peale Chuang, Bernard Fishbach
1Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract:
Serum sickness is an immune-complex mediated illness that frequently occurs in patients after polyclonal antibody therapy (ATGAM or thymoglobulin). Serum sickness presents with significant morbidity but is self-limited and resolves with prolonged steroid therapy. We present five renal transplant patients who developed serum sickness after polyclonal antibody treatment with severe symptoms that persisted after being started on systemic steroids. These patients underwent one or two courses of therapeutic plasma exchange (TPE) with subsequent complete resolution of their symptoms. Renal transplant recipients with serum sickness after polyclonal antibody therapy may benefit from TPE by accelerating their time to recovery and thereby reducing overall morbidity.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant III: Nursing Management
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Kidney Transplant I: Introduction